Effectiveness of Extended-Release Carbamazepine in manic episodes in bipolarity type I
This study is completed in the United States. It is testing Extended-Release Carbamazepine for manic episodes in bipolarity type I.
BipolarityDrugFrom 10 Years to 17 Years
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Then choose your country and confirm availability with each study site.
In plain English
Key information made simple
What is this study testing?
This study is testing whether Extended-Release Carbamazepine may be useful for adolescents experiencing bipolarity.
What would participation involve?
Participants may receive Extended-Release Carbamazepine, attend study visits with the research team. The registry lists locations in the United States.
Who is it mainly for?
This study appears to be mainly for adolescents with bipolarity. Because it involves minors, a parent or guardian may need to be involved.
What should you check before joining?
Ask about the dose, safety monitoring, and possible side effects, whether there is a comparison group, how many visits or travel steps are needed, what role parents or guardians have in the process.
Your next step
Check the study details
Check the official source, then confirm these points with the research team.
Where are visits, can any be remote, and how much time is needed?
Costs and support
What costs, reimbursement or compensation apply?
Before joining
Questions to ask before joining
What are the exact eligibility criteria, and what could exclude someone?
How many visits, assessments, or follow-ups are expected, and over what period?
What risks, side effects, practical burdens, or alternatives should be understood first?
Who should be contacted to confirm locations, timing, compensation, and next steps?
Study clarity
Things to check before joining
Study start dateJuly 2006
Recruitment status
Completed
Enrollment listed in the registry
161
Sponsor
Validus Pharmaceuticals
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United States
Age range
From 10 Years to 17 Years
Official registry ID
NCT00350857
Official title
A Phase IV, Multi-Center, Open-Label, Safety and Effectiveness Study of Extended-Release Carbamazepine in the Treatment of Mania in Children and Adolescents Aged 10-17 Years With Acute Manic or Mixed Bipolar I Disorder.
Ask HopeStage to help me review this study
This record does not confirm open recruitment. We can help you understand it and explore other studies.
Study ID: NCT00350857. We help you review the study, but cannot decide medical eligibility.
Check recruitment and locations
Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.
The overall study status can differ from each site's status. Open a country to see its locations and their registry status.
United States · 26 sites
11 Shire Clinical Research Site
Altamonte Springs, Florida
Site status: Not listed — confirm with the team
17 Segal Institute for Clinical Research
Fort Lauderdale, Florida
Site status: Not listed — confirm with the team
19 Sarkis Clinical Trials
Gainesville, Florida
Site status: Not listed — confirm with the team
23 Shire Clinical Research Site
Jacksonville, Florida
Site status: Not listed — confirm with the team
21 Scientific Clinical Research
North Miami, Florida
Site status: Not listed — confirm with the team
14 Northlake Medical Research
Decatur, Georgia
Site status: Not listed — confirm with the team
04 Mountain West Clinical Trials
Eagle, Idaho
Site status: Not listed — confirm with the team
25 Capstone Clinical Research
Libertyville, Illinois
Site status: Not listed — confirm with the team
15 Psychiatric Associates
Overland Park, Kansas
Site status: Not listed — confirm with the team
27 Owensboro Behavioral Care
Owensboro, Kentucky
Site status: Not listed — confirm with the team
05 Brentwood Research Institute
Shreveport, Louisiana
Site status: Not listed — confirm with the team
13 Pharmasite Research, Inc
Baltimore, Maryland
Site status: Not listed — confirm with the team
02 Finger Lakes Clinical Research
Rochester, New York
Site status: Not listed — confirm with the team
01 Nccacrf
Chapel Hill, North Carolina
Site status: Not listed — confirm with the team
06 University of Cincinnati, College of Medicine
Cincinnati, Ohio
Site status: Not listed — confirm with the team
09 Discovery and Wellness Center for Children
Cleveland, Ohio
Site status: Not listed — confirm with the team
03 IPS Research
Oklahoma City, Oklahoma
Site status: Not listed — confirm with the team
26 Suburban Research Associates
Media, Pennsylvania
Site status: Not listed — confirm with the team
12 Claghorn-Lesem Research Clinic
Bellaire, Texas
Site status: Not listed — confirm with the team
07 Center for Pediatric Psychiatry
Dallas, Texas
Site status: Not listed — confirm with the team
24 Red Oak Psychiatry Associates
Houston, Texas
Site status: Not listed — confirm with the team
10 RID Clinical Research, Inc
Lake Jackson, Texas
Site status: Not listed — confirm with the team
08 Dominion Clinical Research
Midlothian, Virginia
Site status: Not listed — confirm with the team
22 Brighton Research Group
Virginia Beach, Virginia
Site status: Not listed — confirm with the team
20 Shire Clinical Research Site
Milwaukee, Wisconsin
Site status: Not listed — confirm with the team
16 Rogers Center for Research and Training
Milwaukee, Wisconsin
Site status: Not listed — confirm with the team
In practice
For you
Participation may contribute to research. Personal benefit is not guaranteed.
Ask the research team to explain the activities, time commitment, and follow-up involved.
Study sites are listed. Confirm the relevant site and any travel before making plans.
Important
Not medical advice
Information from public sources.
Are you the study sponsor? Contact us to update this page: hi@hopestage.com
FAQ
Questions about this study
What is this study trying to understand?
This study is exploring medication or study treatment for people with bipolarity. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.
Does this study involve a medication?
This appears to be a medication / drug study involving Extended-Release Carbamazepine. Phase 4 studies usually happen after treatment approval, to monitor real-world use.
Who might this study be for?
This study may concern people with bipolarity; age range: From 10 Years to 17 Years. The criteria appear fairly specific, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.
What would I likely need to do?
You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.
What side effects, interactions, or treatment changes should I check?
If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.
Will I need to travel or attend in-person visits?
The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.
Who is behind this study?
This study is sponsored by Validus Pharmaceuticals, which appears to be unknown or unclear. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.
Can I still join this study?
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Explore other studies
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
